Octreotide Acetate
Gastrointestinal & peptide biology
It has extensive clinical research in acromegaly, secretory syndromes of certain neuroendocrine tumors, and gastroenteropancreatic neuroendocrine tumour research.
An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.
What is Octreotide Acetate?
Octreotide acetate is a synthetic somatostatin analogue octapeptide used extensively as a research reagent in endocrine and neuroendocrine studies of somatostatin receptor pharmacology; the catalogue label denotes the acetate salt.
Which research context has Octreotide Acetate been associated with?
Octreotide Acetate is associated with gastrointestinal peptide biology and clinical research as a synthetic somatostatin analogue peptide extensively studied in acromegaly, secretory syndromes of neuroendocrine tumours and GEP NET contexts, including receptor pharmacology and symptom management trials.
What documentation is available for Octreotide Acetate?
Octreotide Acetate: Batch documents are not yet linked on this site. For this synthetic somatostatin analogue peptide the checklist comprises batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity criteria; peptide content, counterion and residual solvent/water details; and assay/potency documentation supporting release. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Octreotide Acetate?
Octreotide Acetate: Storage depends on the documented supplied presentation; as a synthetic somatostatin analogue peptide verify dry/lyophilised versus solution form, counterion and concentration, solvent or buffer composition, pH sensitivity, container closure compatibility and cyclic/conformational stability including oxidation risk. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.